Basal lamina characterization in frozen-thawed and long-term grafted human prepubertal ovarian tissue

2021 ◽  
Vol 42 (5) ◽  
pp. 859-869
Author(s):  
Charlotte Philippart ◽  
Rossella Masciangelo ◽  
Alessandra Camboni ◽  
Jacques Donnez ◽  
Marie-Madeleine Dolmans
Keyword(s):  
2011 ◽  
Vol 28 (12) ◽  
pp. 1157-1165 ◽  
Author(s):  
Christiani A. Amorim ◽  
Anu David ◽  
Marie-Madeleine Dolmans ◽  
Alessandra Camboni ◽  
Jacques Donnez ◽  
...  

2018 ◽  
Vol 110 (7) ◽  
pp. 1356-1366 ◽  
Author(s):  
Vincenza Barbato ◽  
Roberto Gualtieri ◽  
Teresa Capriglione ◽  
Maria Michela Pallotta ◽  
Sabrina Braun ◽  
...  

2019 ◽  
Vol 35 (6) ◽  
pp. 470-472 ◽  
Author(s):  
R. Fabbri ◽  
R. Seracchioli ◽  
R. Vicenti ◽  
R. Paradisi ◽  
S. Rossi ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-17 ◽  
Author(s):  
Joselyn Rojas ◽  
Mervin Chávez ◽  
Luis Olivar ◽  
Milagros Rojas ◽  
Jessenia Morillo ◽  
...  

Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine-metabolic disorder that implies various severe consequences to female health, including alarming rates of infertility. Although its exact etiology remains elusive, it is known to feature several hormonal disturbances, including hyperandrogenemia, insulin resistance (IR), and hyperinsulinemia. Insulin appears to disrupt all components of the hypothalamus-hypophysis-ovary axis, and ovarian tissue insulin resistance results in impaired metabolic signaling but intact mitogenic and steroidogenic activity, favoring hyperandrogenemia, which appears to be the main culprit of the clinical picture in PCOS. In turn, androgens may lead back to IR by increasing levels of free fatty acids and modifying muscle tissue composition and functionality, perpetuating this IR-hyperinsulinemia-hyperandrogenemia cycle. Nonobese women with PCOS showcase several differential features, with unique biochemical and hormonal profiles. Nevertheless, lean and obese patients have chronic inflammation mediating the long term cardiometabolic complications and comorbidities observed in women with PCOS, including dyslipidemia, metabolic syndrome, type 2 diabetes mellitus, and cardiovascular disease. Given these severe implications, it is important to thoroughly understand the pathophysiologic interconnections underlying PCOS, in order to provide superior therapeutic strategies and warrant improved quality of life to women with this syndrome.


2012 ◽  
Vol 27 (8) ◽  
pp. 2420-2429 ◽  
Author(s):  
N. Suzuki ◽  
S. Hashimoto ◽  
S. Igarashi ◽  
S. Takae ◽  
M. Yamanaka ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document